
KD Pharma Group is a leading CDMO for Pharmaceutical and Nutraceutical Solutions The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites BIOGGO, EUROPE, SWITZERLAND, July 18, 2024 /EINPresswire.com/ — The KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, […]
The post KD Pharma Group to acquire dsm-firmenich’s marine lipids business in exchange for a minority stake in the company first appeared on Beauty Ring.
